Riskpilot← Back to searchSign inGet full accessSKIPTVET APOTEK AS
ASActiveOrg 926404172Langnesveien 2, 1815 AskimRetail sale of pharmaceutical products · NACE 4773Est. 20210 employees
Revenue 2023
NOK 15,6M
+54% vs 2022
EBITDA margin
7.7%
+620% vs 2022
Equity ratio
14.7%
Financial strength
Net profit 2023
NOK 810K
+255% vs 2022
| Revenue | NOK 15,6M | +54% |
| EBITDA | NOK 1,2M | +620% |
| Net profit | NOK 810K | +255% |
| Total assets | NOK 5M | +51% |
| Equity | NOK 729K | +999% |
| Employees | 0 | — |
Legal name
SKIPTVET APOTEK AS
Org number
926404172
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
18. januar 2021
Share capital
NOK 400 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Langnesveien 2, 1815 Askim
Phone
+4769696969
Email
hurraholet@vitusapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 5 770 | 10 169 | 15 613 |
| Staff expenses | −1 108 | −2 541 | −2 314 |
| EBITDA | 262 | −231 | 1 201 |
| Depreciation & amort. | −161 | −243 | −246 |
| EBIT | 101 | −475 | 955 |
| Net financials | −53 | −59 | −53 |
| Profit before tax | 48 | −533 | 902 |
| Tax | 9 | −9 | 92 |
| Net profit | 38 | −524 | 810 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 4 244 | 3 286 | 4 952 |
| Equity | 443 | −81 | 729 |
| Long-term debt | 1 731 | 1 348 | 994 |
| Short-term debt | 2 070 | 2 018 | 3 228 |
| Total debt | 3 801 | 3 367 | 4 223 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20212023
Equity ratio
14.7%
This company
38.2%
Market median
-62% vs market
20212023
Return on equity
111.1%
This company
18.4%
Market median
+504% vs market
20212023
Net profit margin
5.2%
This company
8.1%
Market median
-36% vs market
20212023
Asset turnover
3.15×
This company
1.12×
Market median
+181% vs market
20212023
Debt / equity
5.79×
This company
0.62×
Market median
-834% vs market
20212023
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
VH Contact Person | Contact Person | 2024 |
| Former (1) | ||
GA Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Chairman | 2021 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2023 | |
| Company | 25% | 25% | 2023 | |
| Company | 25% | 25% | 2023 | |
| Company | 25% | 25% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Apoinvest Holding As
SKIPTVET APOTEK AS Board members of SKIPTVET APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vegard Hoff | Contact Person | 0 companies |
| Gulzeb Aziz | Chief Executive Officer | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Kurt Leon Haga | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |